OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early Access to Oral Antivirals in High-Risk Outpatients: Good Weapons to Fight COVID-19
Giuseppe Bruno, Massimo Giotta, Serena Perelli, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2514-2514
Open Access | Times Cited: 13
Giuseppe Bruno, Massimo Giotta, Serena Perelli, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2514-2514
Open Access | Times Cited: 13
Showing 13 citing articles:
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1175-1185
Open Access | Times Cited: 33
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1175-1185
Open Access | Times Cited: 33
Real-World Clinical Outcomes of Molnupiravir for the Treatment of Mild to Moderate COVID-19 in Adult Patients during the Dominance of the Omicron Variant: A Meta-Analysis
Chienhsiu Huang, Tsung-Lung Lu, Lichen Lin
Antibiotics (2023) Vol. 12, Iss. 2, pp. 393-393
Open Access | Times Cited: 17
Chienhsiu Huang, Tsung-Lung Lu, Lichen Lin
Antibiotics (2023) Vol. 12, Iss. 2, pp. 393-393
Open Access | Times Cited: 17
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study
Carlo Torti, Pier Paolo Olimpieri, Paolo Bonfanti, et al.
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100684-100684
Open Access | Times Cited: 10
Carlo Torti, Pier Paolo Olimpieri, Paolo Bonfanti, et al.
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100684-100684
Open Access | Times Cited: 10
Factors Associated with Pneumonia in Patients Hospitalized with COVID-19 and the Role of Vaccination
Antonella Zizza, Raffaella Sedile, Francesco Bagordo, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1342-1342
Open Access | Times Cited: 5
Antonella Zizza, Raffaella Sedile, Francesco Bagordo, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1342-1342
Open Access | Times Cited: 5
A new approach for identifying innate immune defects
Ludwig Englmeier, Michael H. Sieweke, Jessica Nitsche, et al.
Diagnosis (2024) Vol. 11, Iss. 4, pp. 457-459
Closed Access | Times Cited: 1
Ludwig Englmeier, Michael H. Sieweke, Jessica Nitsche, et al.
Diagnosis (2024) Vol. 11, Iss. 4, pp. 457-459
Closed Access | Times Cited: 1
Bile Acids and SARS-CoV-2: Ursodeoxycholic Acid as a Potential Treatment of COVID-19
Stefano Fiorucci, Ginevra Urbani, Eleonora Distrutti
Recent Advances in Inflammation & Allergy Drug Discovery (2023) Vol. 17, Iss. 1, pp. 2-6
Closed Access | Times Cited: 2
Stefano Fiorucci, Ginevra Urbani, Eleonora Distrutti
Recent Advances in Inflammation & Allergy Drug Discovery (2023) Vol. 17, Iss. 1, pp. 2-6
Closed Access | Times Cited: 2
Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study
Takashi Sakaguchi, Akihiko Mitsuke, Yoichi Osako, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access
Takashi Sakaguchi, Akihiko Mitsuke, Yoichi Osako, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access
Safety of RNA-Dependent RNA Polymerase Inhibitors, Molnupiravir and VV116, for Oral Treatment of COVID-19: A Meta-Analysis.
Zequn Zheng, Jiaozhi Zhou, Yongfei Song
PubMed (2024) Vol. 49, Iss. 5, pp. 275-285
Closed Access
Zequn Zheng, Jiaozhi Zhou, Yongfei Song
PubMed (2024) Vol. 49, Iss. 5, pp. 275-285
Closed Access
Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan
Naoki Hosogaya, Takahiro Takazono, Kenji Kurazono, et al.
Advances in Therapy (2023) Vol. 40, Iss. 8, pp. 3525-3542
Open Access | Times Cited: 1
Naoki Hosogaya, Takahiro Takazono, Kenji Kurazono, et al.
Advances in Therapy (2023) Vol. 40, Iss. 8, pp. 3525-3542
Open Access | Times Cited: 1
Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in Israel
Clara Weil, Tobias Bergroth, Anna Eisenberg, et al.
Epidemiologia (2023) Vol. 4, Iss. 3, pp. 309-321
Open Access | Times Cited: 1
Clara Weil, Tobias Bergroth, Anna Eisenberg, et al.
Epidemiologia (2023) Vol. 4, Iss. 3, pp. 309-321
Open Access | Times Cited: 1
Molnupiravir/nirmatrelvir/ritonavir
Reactions Weekly (2023) Vol. 1953, Iss. 1, pp. 253-253
Closed Access
Reactions Weekly (2023) Vol. 1953, Iss. 1, pp. 253-253
Closed Access
A Simple Assay for Identifying Innate Immune Defects Upstream of Nf-Kb – A Case Report
Ludwig Englmeier, Michael H. Sieweke, Jessica Nitsche, et al.
Research Square (Research Square) (2023)
Open Access
Ludwig Englmeier, Michael H. Sieweke, Jessica Nitsche, et al.
Research Square (Research Square) (2023)
Open Access
Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study
Xue Zhong, Chao Wang, Lin Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access
Xue Zhong, Chao Wang, Lin Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access
